Altamira Therapeutics Ltd. Current Tax Expense Income
Altamira Therapeutics Ltd. (CYTOF) reported Current Tax Expense Income of -CHF 1.23 thousand for the 6-month period ending 2022-06-30, per its 6-K filed 2023-09-12.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:CurrentTaxExpenseIncome · last filed 2023-09-12
- 2022-06-30: Current Tax Expense Income 6 month -1.23K CHF.
| Period end | Current Tax Expense Income 6 month |
|---|---|
| 2022-06-30 | -1.23K CHF 6-K · filed 2023-09-12 |